Abstract:Determining the presence of paraquat (PQ) and diquat (DQ) in urine samples through physical and chemical testing is challenging. As PQ and DQ have characteristics such as high molecular polarity and good water solubility, they are difficult to be retained by conventional reversed-phase columns. Most of the methods in the literature use hydrophilic interaction chromatography (HILIC) for the retention of PQ and DQ, but they often require high concentrations of buffer salts as the mobile phase, which increase the contamination of the mass spectrometer. In view of the above problems, a rapid and accurate analysis method was developed for the determination of PQ and DQ residuals in urine samples based on weak cation exchange (WCX) solid-phase extraction (SPE) and ultra performance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS) in this study. Urine samples were first diluted with phosphate buffer (pH=6.86) and pretreated using the WCX SPE method. Chromatographic separation was performed on a Syncronis HILIC column (100 mm×2.1 mm, 1.7 μm). An electrospray ion source in the positive (ESI+) mode and full mass-data dependent MS2 (full mass-ddMS2) mode was used for quantification by matrix-matched external standard method. In this study, the concentration of ammonium formate in the mobile phase in the HILIC mode was effectively reduced to 10 mmol/L by the continuous optimization of the chromatographic conditions. MS optimization results indicated that the molecular ion (M+·) of PQ and DQ had the strongest response. In addition, sample pretreatment conditions were also optimized. The obtained results indicated that the hydrophobic polytetrafluoroethylene (PTFE) filter membrane, acetonitrile-water (1∶1, v/v) as a fixing solution, and polypropylene vials were suitable for PQ and DQ analysis. Under the optimal conditions, the linearity of PQ and DQ was good with correlation coefficients (r2) greater than 0.998. The limits of detection (LODs, S/N≥3) and limits of quantification (LOQs, S/N≥10) were 0.2 μg/L and 0.6 μg/L, respectively. Mean spiked recoveries of PQ and DQ at the four spiked levels (1.0, 20.0, 100.0, and 200.0 μg/L) were in the range of 85.8%-101% and 80.3%-86.9%, with the RSDs of 0.8%-5.1% and 0.9%-4.2%. The established method was employed for the analysis and confirmation of PQ and DQ for clinical poisoning cases. In one case, a 23-year-old male who had taken approximately 20 mL of pesticide orally was confirmed as DQ poisoning by the developed method. DQ concentration monitoring of the urine samples was conducted for this case during the clinical treatment process. The patient was successfully discharged from the hospital after five times of blood perfusion and other treatments until the DQ concentration was low in the urine samples. In conclusion, the method developed in this study based on WCX SPE-UPLC-HRMS can be used for the confirmation of poisoning cases and concentration monitoring during clinical treatment, providing strong technical support for clinical precision treatment. The method is rapid, simple, sensitive, and accurate, and it is suitable for the detection of PQ and DQ in urine samples.

Determination of Pralidoxime Iodide in Human Plasma and Urine by Reversed - Phase High Performance Liquid Chromatography

[Determination of paraquat and diquat residues in urine samples based on solid-phase extraction and ultra performance liquid chromatography-high resolution mass spectrometry]

Determination of Atropine in Plasma and Urine by HPLC

Unveiling Novel Chaotropic Chromatography Method for Determination of Pralidoxime in Nerve Agent Antidote Autoinjectors

Speciation analysis of urine iodine by ion-pair reversed-phase liquid chromatography and inductively coupled plasma mass spectrometry

A Simple and Rapid Method for Detection of Paraquat in Human Plasma by High-Performance Liquid Chromatography.

Determination of Levodropropizine by Reversed Phase High Performance Liquid Chromatography with Chemiluminescence Detection

Determination of olprinone in human plasma utilizing liquid chromatography tandem mass spectrometry.

Determination of Amodiaquine in Human Plasma by High Performance Liquid Chromatography

Flow-injection On-Line Oxidizing Fluorimetry and Solid Phase Extraction for Determination of Thioridazine Hydrochloride in Human Plasma.

LC -MS Determination of Propiverine in Human Plasma

Determination of Pilsicainide in Human Plasma and Urine by LC-MS /MS

Simultaneous determination of diquat, paraquat, glufosinate, and glyphosate in plasma by liquid chromatography/tandem mass spectrometry: from method development to clinical application

Development and Validation of a RP-HPLC Method for Determination of Pidotimod in Plasma and its Efficient Application to a Pharmacokinetic Study

Simultaneous determination of paraquat and diquat in human plasma by HPLC‐DAD: Its application in acute poisoning patients induced by these two herbicides

Reversed-phase ion-pair chromatography-diode array detection of the bispyridinium compound MB327: plasma analysis of a potential novel antidote for the treatment of organophosphorus poisoning

Dispersive Liquid-Liquid Microextraction Combined with High-Performance Liquid Chromatography for the Determination of Clozapine and Chlorpromazine in Urine

Optimized Ultra Performance Liquid Chromatography Tandem High Resolution Mass Spectrometry Method for the Quantification of Paraquat in Plasma and Urine

Determination of the Concentration of Dipyridamole in Human Plasma by HPLC

HPLC-MS determination of flupentixol in the human plasma and its bioequivalence

DETERMINATION OF SULFAMETHOXAZOLE AND IT'S METABOLITE IN HUMAN PLASMA AND PHARMACOKINETICS STUDY BY HPLC